COVID-19 primary infection, reinfection, and its associated clinical presentations

Introduction: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), which caused primary COVID-19 infection in millions worldwide, raised significant concerns as viral mutations emerged, leading to reinfections among previously infected and vaccinated individuals. This phenomenon became particularly evident during the second and third waves of the COVID-19 pandemic in India. Methods: The current study observed the rates of reinfections due to SARS-CoV-2 and their relation to vaccination details by retrospectively analyzing the data of patients who had reinfections during the second and third waves of COVID-19. Results: < 0.01). Conclusions: SARS-CoV-2 is re-emerging with new variants and varied presentations, posing a challenge to clinicians regarding specific diagnoses. The symptoms of COVID-19 during primary and re-infection did not differ greatly. Although vaccination protects individuals against reinfections, the exact duration of protection remains unknown and may necessitate booster doses at frequent intervals.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-04-14
DOI
https://doi.org/10.3389/fpubh.2026.1695310
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID-19 primary infection, reinfection, and its associated clinical presentations

Vidyavathi B. Chitharagi, Yogeesh D. Maheshwarappa, Morubagal Raghavendra Rao, Varuni Makam et al.
Frontiers in Public Health
SARS-CoV-2 and COVID-19 Research
article

COVID-19 primary infection, reinfection, and its associated clinical presentations

Vidyavathi B. Chitharagi, Yogeesh D. Maheshwarappa, Morubagal Raghavendra Rao, Varuni Makam, Tejashree A., Smitha Chandrashekarappa
article en

Abstract

Introduction: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), which caused primary COVID-19 infection in millions worldwide, raised significant concerns as viral mutations emerged, leading to reinfections among previously infected and vaccinated individuals. This phenomenon became particularly evident during the second and third waves of the COVID-19 pandemic in India. Methods: The current study observed the rates of reinfections due to SARS-CoV-2 and their relation to vaccination details by retrospectively analyzing the data of patients who had reinfections during the second and third waves of COVID-19. Results: < 0.01). Conclusions: SARS-CoV-2 is re-emerging with new variants and varied presentations, posing a challenge to clinicians regarding specific diagnoses. The symptoms of COVID-19 during primary and re-infection did not differ greatly. Although vaccination protects individuals against reinfections, the exact duration of protection remains unknown and may necessitate booster doses at frequent intervals.

Frontiers in Public HealthVol. 14
JSS Academy of Higher Education and Research (IN)
JSS Academy of Higher Education and Research, Indian Council of Medical Research
Good health and well-being
Openalex Percentile: Top 22%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.